Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

BOIRON : 2021 results


The Board of Directors of BOIRON, at its meeting on March 9, 2022 chaired by Thierry Boiron, made up the statutory and consolidated financial statements of the financial year ended on December 31, 2021. It was decided to call a Shareholders' Meeting on May 19, 2022 at the company's headquarters in Messimy.

Audit of the statutory and consolidated financial statements have been performed and the audit reports concerning their certification are currently in the process of being issued.

BOIRON GROUP RESULTS

In thousands of euros 2021 2020 Variation
Sales(1) 455,201 513,582 -11.4%(2)
Operating income 46,842 38,185 +22.7%
Net income - Group share 28,556 26,209 +9.0%
       
Cash flow(3) 55,639 104,944 -47.0 %
Net investments 11,921 19,336 -38.3%
Net cash position 234,082 234,313 -0.1%

(1) The main information on the variation of the yearly sales were the subject of a financial statement on January 20, 2022 (https://www.boironfinance.fr/en/releases/sales).
(2)  -10.6% at constant exchange rate.
(3) Before cash revenue, financing expenses and corporate income tax.

Full-year operating income amounted to €46,842 thousand. Despite the decline in sales, it benefited from the launch of new products and the implementation of a global savings plan.

The reorganisation plan in France is being implemented as planned. In 2021 it gave rise to a disbursement of €15,510 thousand. The remainder of the provision amounted to €43,241 thousand at December 31, 2021. The impacts of the reorganisation costs on operating income were as follows:

In thousands of euros 2021 2020
Operating income 46,842 38,185
Net impact of reorganisation -1,290 -32,719
Operating income before impact of reorganisation 48,132 70,904
% of revenue 10.6% 13.8%

As such, before accounting for the impact of reorganisation costs, 2021 operating income amounted to €48,132 thousand, owing to:

  • the decrease in revenues, which had a €67,120 thousand negative impact on the gross margin (following the delisting of homeopathy from French health insurance on January 1, and the absence of winter illnesses in the first quarter due to the global health crisis),
  • the reduction in preparation and distribution costs following the reorganisation in France and the ongoing implementation of a global savings plan, resulting in a €37,510 thousand reduction in overall operating expenses,
  • the €6,838 thousand increase in gains on disposals following the sale of eight preparation and distribution facilities.

The Board of Directors will recommend that the General Meeting of Shareholders distribute a dividend of 0.95 euros per share. The dividend will be paid out on June 3, 2022.

As announced in the January 20 release, on February 28, Laboratoires Boiron purchased 70% of the share capital of ABBI, a start-up specialising in personalized and customized cosmetics.

Due to a resurgence in winter illnesses, the impact of new product launches, and continued sales of COVID tests in the first months of the year, we expect to post sales growth in 2022.

However, Group sales will potentially be impacted by the war in Ukraine that began at the end of February 2022. It is of concern to all of our teams and affects our Ukrainian distributor, leading us to set up a crisis committee to manage the social and economic impacts of the situation on our distributor and our Russian subsidiary's activities. Sales generated in Ukraine and Russia in 2021 accounted for less than 4% of Group revenues. We are keeping a close eye on the situation, in order to take the necessary actions for organizing our operations.

We continue to put all our energy and determination into the promotion of Homeopathy in France and around the world.

Laboratoires BOIRON

Our next update:
April 21, 2022, at market close, publication of quarterly sales and financial information as of March 31, 2022.
Person responsible for financial information: Valérie Lorentz-Poinsot
Contact for financial information: Fabrice Rey
Investor relations: +33 (0) 4.37.41.84.01 - e-mail: boironfinances@boiron.fr
ISIN Code: FR0000061129 (BOI) - Bloomberg: BOI FP - Reuters: BOIR.PA
The group's financial information is online at: www.boironfinance.com



This publication embed "🔒 Actusnews SECURITY MASTER".
- SECURITY MASTER Key: x2dulZhsk2eXmHFslcdqb2VpaWmSk2HHm2SYmWNslJaabnBoyJtqbsXGZnBkmmhn
- Check this key: https://www.security-master-key.com.



Regulated information:
Inside Information:
- News release on accounts, results


Full and original press release in PDF: https://www.actusnews.com/news/73531-boi-090322-ra-21-gb.pdf

Receive by email the next press releases of the company by registering on www.actusnews.com, it's free

Source Actusnews

Boiron S.A. Stock

€40.70
0.620%
The Boiron S.A. stock is trending slightly upwards today, with an increase of €0.25 (0.620%) compared to yesterday's price.
With 0 Sell predictions and 1 Buy predictions the community sentiment towards the Boiron S.A. stock is not clear.
Like: 0
Share

Comments